Intervention With Lupin Kernel Fibre in Hypercholesterolemic Subjects

Sponsor
University of Jena (Other)
Overall Status
Completed
CT.gov ID
NCT01035086
Collaborator
German Federal Ministry of Education and Research (Other)
54
1
3
6
9

Study Details

Study Description

Brief Summary

The objective of the conducted study was to determine the efficacy of lupin kernel fibre-enriched food (Lupinus angustifolius Boregine) on prevention of risk factors for gastrointestinal or cardiovascular diseases.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: fabricated food
N/A

Detailed Description

Dietary fibre is suspected to effect the faecal concentration and excretion of bile acids by binding the bile acids and by increasing the faecal mass. Bile acids, especially the secondary bile acids, are potential risk factors for colorectal cancer. A high bile acid-binding ability of fibre could lead to lower blood cholesterol concentrations by interrupting the enterohepatic circulation. There is evidence that the consumption of lupin kernel fibre, containing both soluble and insoluble fibre fractions, may beneficially modify bowel health.

A total of 133 subjects were recruited for this study. Sixty moderate hypercholesterolemic volunteers (total cholesterol > 5.2 mmol/L) fulfilled the selection criteria and were randomly assigned three groups. Forty-five subjects (mean age of 47 years, 34 women and 20 men) completed the double-blind, randomized crossover trial.

The subjects consumed a high-fibre diet containing 25 g fibre (citrus- or lupin fibre) per day and a low-fibre diet (placebo) for four weeks each. After baseline, each volunteer had to pass all three periods in different order with a two-week wash-out period between each.

At the end of each intervention period, subjects consumed a standardized diet for three days. Furthermore, a quantitative stool collection took place and fasting blood samples were drawn.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Preventive Effects of Lupin Kernel Fibre-enriched Food on Colon Cancer and Cardiovascular Diseases in Moderate Hypercholesterolemic Subjects
Study Start Date :
Jun 1, 2008
Actual Primary Completion Date :
Dec 1, 2008
Actual Study Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Boregine

Intervention: Lupinus angustifolius Boregine; 25 g lupin kernel fibre per day over 4 weeks; lupin kernel fibre was incorporated in different food

Dietary Supplement: fabricated food
The subjects consumed a high-fibre diet containing 25 g fibre (citrus- or lupin fibre) per day and a low-fibre diet (placebo) for four weeks each. After a one-week run-in period, each volunteer had to pass all three periods (arms) in different order with a two-week wash-out period between each.
Other Names:
  • diet
  • Active Comparator: Reference

    Intervention: Reference fibre (citrus fibre: Herbacel AQ Plus; Herbafood ingredients); 25 g citrus fibre per day over 4 weeks; the citrus fibre was incorporated in different food

    Dietary Supplement: fabricated food
    The subjects consumed a high-fibre diet containing 25 g fibre (citrus- or lupin fibre) per day and a low-fibre diet (placebo) for four weeks each. After a one-week run-in period, each volunteer had to pass all three periods (arms) in different order with a two-week wash-out period between each.
    Other Names:
  • diet
  • Placebo Comparator: Placebo

    different food without added fibre

    Dietary Supplement: fabricated food
    The subjects consumed a high-fibre diet containing 25 g fibre (citrus- or lupin fibre) per day and a low-fibre diet (placebo) for four weeks each. After a one-week run-in period, each volunteer had to pass all three periods (arms) in different order with a two-week wash-out period between each.
    Other Names:
  • diet
  • Outcome Measures

    Primary Outcome Measures

    1. cholesterol metabolism (blood lipids) [after 1, 5, 10 and 15 weeks]

    Secondary Outcome Measures

    1. general excretion parameters, neutral sterols, bile acids, short-chain fatty acids, fibre excretion, cytotoxicity, genotoxicity [after 1, 5, 10 and 15 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • moderate Hypercholesterolemia (total cholesterol > 5.2 mmol/L)

    • age 20-75 years

    Exclusion Criteria:
    • intake of lipid-lowering pharmaceuticals

    • intake of nutritional supplements

    • allergy against legumes

    • intolerance against milk protein

    • pregnancy, lactation

    • chronic bowel diseases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutrional Physiology Jena Thuringia Germany D-07743

    Sponsors and Collaborators

    • University of Jena
    • German Federal Ministry of Education and Research

    Investigators

    • Principal Investigator: Gerhard Jahreis, Prof. Dr., Friedrich Schiller University Jena, Institute of Nutrition, Department of Nutrional Physiology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gerhard Jahreis, Prof. Dr. G. Jahreis, University of Jena
    ClinicalTrials.gov Identifier:
    NCT01035086
    Other Study ID Numbers:
    • LSEP H36-08
    First Posted:
    Dec 18, 2009
    Last Update Posted:
    Dec 5, 2012
    Last Verified:
    Dec 1, 2012
    Keywords provided by Gerhard Jahreis, Prof. Dr. G. Jahreis, University of Jena
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 5, 2012